NN2211-4077 Retrospective collection of effectiveness and safety data from patients treated with liraglutide or DPP-4 inhibitor in primary care in EuropeFirst published 27/02/2015 Last updated 02/04/2024 EU PAS number: EUPAS8135StudyFinalised
Global Clinical Registry (GCR, 1452) Novo Nordisk pactadmin@novonordisk.comStudy contactpactadmin@novonordisk.com